ES8802384A1 - Procedimiento para 6-substituido-2-(1h) quinolinonas. - Google Patents

Procedimiento para 6-substituido-2-(1h) quinolinonas.

Info

Publication number
ES8802384A1
ES8802384A1 ES550354A ES550354A ES8802384A1 ES 8802384 A1 ES8802384 A1 ES 8802384A1 ES 550354 A ES550354 A ES 550354A ES 550354 A ES550354 A ES 550354A ES 8802384 A1 ES8802384 A1 ES 8802384A1
Authority
ES
Spain
Prior art keywords
cardiotonic
antihypertensive
quinolinones
substituted
related compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550354A
Other languages
English (en)
Other versions
ES550354A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES550354A0 publication Critical patent/ES550354A0/es
Publication of ES8802384A1 publication Critical patent/ES8802384A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LAS 6-SUSTITUIDO-2-(1H) QUINOLINONAS (I), DONDE NO EXCLUSIVAMENTE, X ES (CH2)N CON N 1 O 2, R Y R1 SON HIDROGENO O ALQUILO INFERIOR Y R2 Y R3 HIDROGENO O JUNTOS Y CON SU UNION A CARBONO FORMAN ANILLO DE 3 A 6 MIEMBROS; SE OBTIENEN HACIENDO REACCIONAR UNA QUINOLONA (II), DONDE ALK ALQUILO C1-4, CON UN R1NHNH2 EN UN DISOLVENTE COMO ETANOL, CALENTANDO A REFLUJO DURANTE 4 HORAS. ESTOS COMPUESTOS PRESENTAN IC50 DE 3,5D10C7 M CONTRA LA AGREGACION INDUCIDA POR COLAGENO Y UN IC50 DE 4,5D10C6 M CONTRA LA INDUCIDA POR ADP, SIENDO APLICABLE AL TRATAMIENTO DE LA TROMBOSIS, HIPERTENSION Y OTRAS ENFERMEDADES TRATADAS CONVENIENTEMENTE CON INHIBIDORES DE LA AGREGACION DE PLAQUETAS.
ES550354A 1984-12-24 1985-12-23 Procedimiento para 6-substituido-2-(1h) quinolinonas. Expired ES8802384A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68563984A 1984-12-24 1984-12-24

Publications (2)

Publication Number Publication Date
ES550354A0 ES550354A0 (es) 1988-05-16
ES8802384A1 true ES8802384A1 (es) 1988-05-16

Family

ID=24753060

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550354A Expired ES8802384A1 (es) 1984-12-24 1985-12-23 Procedimiento para 6-substituido-2-(1h) quinolinonas.

Country Status (6)

Country Link
EP (1) EP0188917A1 (es)
JP (1) JPS61158979A (es)
AU (1) AU589923B2 (es)
DK (1) DK577085A (es)
ES (1) ES8802384A1 (es)
ZA (1) ZA859091B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2516040C2 (de) * 1974-06-10 1984-12-20 Dr. Karl Thomae Gmbh, 7950 Biberach Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
GB2031404A (en) * 1978-10-17 1980-04-23 Yoshitomi Pharmaceutical Pyridazinone compounds
US4550119A (en) * 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
GR851296B (es) * 1984-05-29 1985-11-25 Pfizer

Also Published As

Publication number Publication date
JPS61158979A (ja) 1986-07-18
DK577085D0 (da) 1985-12-12
ES550354A0 (es) 1988-05-16
EP0188917A1 (en) 1986-07-30
ZA859091B (en) 1987-07-29
DK577085A (da) 1986-06-25
AU5046685A (en) 1986-07-03
AU589923B2 (en) 1989-10-26

Similar Documents

Publication Publication Date Title
PH31082A (en) Azole compounds, their production and use.
CA2054209A1 (en) Antihyperlipidemic and antiatherosclerotic urea compounds
GR3006163T3 (es)
ES8203388A1 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
IE791895L (en) Alkanoyl prolines.
US4167625A (en) Trans-4,5,13,14-tetradehydro-PGI1 amides
ES8705425A1 (es) Un compuesto.
ATE50773T1 (de) Alkylresorcinolphosphite.
ZA894716B (en) Esters
IE780182L (en) N-9,10-DIHYDROLYSERGYL-m-AMINOBENZOIC ACID AMIDES.
CA1273641C (en) ALCENIC DERIVATIVES OF L-AMINOCARBOXYLIC ACIDS
NZ304438A (en) Substituted triazole derivatives and antifungal compositions
US4138549A (en) Inter-phenylene-PG pyrrolinylamides
DE3563967D1 (en) Tris(beta,beta-dimethylphenethyl)tin compounds
ES8306999A1 (es) Procedimiento para preparar nuevos derivados de etenilimidazol.
ES8802384A1 (es) Procedimiento para 6-substituido-2-(1h) quinolinonas.
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ZA825576B (en) Benzodioxane-imidazoline compounds as antihypertensives
EG17841A (en) New-benzotriazoles the preparation thereof and their use as fungicides
ATE105565T1 (de) Pradimicinderivate.
ES2024332A6 (es) Procedimiento para la obtencion de nuevas sulfonamidas.
US4164501A (en) 2-Decarboxy-2-hydroxymethyl-trans-4,5,13,14-tetradehydro-PGI1 compounds
IE830733L (en) Pyrazinylthiazine derivatives
US4164502A (en) 2-Decarboxy-2-aminomethyl-trans-4,5,13,14-tetradehydro-PGI1 compounds
ES8603393A1 (es) Procedimiento para preparar composiciones fungicidas